| 25.94 Data as of 12:34pm ET |  -0.56 / -2.11%Today’s Change | 7.07 Today|||52-Week Range 31.15 | +59.04% Year-to-Date |
| Previous close | 26.50 |
| Today’s open | 26.43 |
| Day’s range | 24.00 - 26.50 |
| Volume | 107,621 |
| Average volume (3 months) | 45,840 |
| Market cap | $711.4M |
| Dividend yield | -- |
| Earnings growth (last year) | +136.99% |
| Earnings growth (this year) | +3.91% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +20.72% |
| P/E ratio | 15.3 |
| Price/Sales | 2.31 |
| Price/Book | 3.61 |
| Today’s change | Today’s % change | |
|---|---|---|
| OPTROptimer Pharmaceutic... | -0.16 | -1.09% |
| ACHNAchillion Pharmaceut... | -0.19 | -2.49% |
| AUXLAuxilium Pharmaceuti... | +0.07 | +0.46% |
| ARRYArray Biopharma Inc | +0.16 | +2.82% |
| Next reporting date | August 19, 2013 |
| EPS forecast (this quarter) | $0.48 |
| Annual revenue (last year) | $184.8M |
| Annual profit (last year) | $45.2M |
| Net profit margin | 24.47% |
Sector Health Technology |
Industry Biotechnology |
Executive Chairman, President & CEO David Xiaoying Gao, MBA |
Chief Financial Officer Ming Yang |
Corporate headquarters Beijing, Beijing |
.
